John Makohen, CASAC emerging research into psychedelics, ketamine, and neuroplasticity, and how they are reshaping conversations around recovery and mental health.

Joshua Bennett-Johnson, LADC-II's, firsthand recovery experience reveals the complex role of RX medication in his treatment plan.

Harm reduction meets people where they are - without requiring abstinence as the starting point. Dr. Andrew Tatarsky's article explains how that shift expands treatment access and improves outcomes.